Fingerprint
Dive into the research topics of 'Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: A retrospective study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: A retrospective study
Shimpei Maeda, Fuyuhiko Motoi, Tohru Onogawa, Takanori Morikawa, Ottomo Shigeru, Naoaki Sakata, Tatsuyuki Takadate, Takeshi Naito, Toshiki Rikiyama, Yu Katayose, Shinichi Egawa, Michiaki Unno
Research output: Contribution to journal › Article › peer-review
27
Citations
(Scopus)